Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic, Wegovy.
Source: US Top News and Analysis
Related Posts
Analysis: A new oil shock is building. The next few weeks of war will be decisive for the economy.
A new oil shock is building as the conflict in the Middle East escalates, with…
Gas prices should soon start slowly easing if ceasefire holds, analysts say
With oil prices plunging after the U.S. and Iran agreed to a two-week ceasefire, gas…
Tesla reports 358,000 first-quarter vehicle deliveries, down 14% from last quarter
Tesla is coming off a year of declining deliveries due in part to increased competition…